Cargando…

Evaluation of T cell infiltration in matched biopsy and nephrectomy samples in renal cell carcinoma

T cell infiltration in tumors has been investigated as a biomarker of response to checkpoint inhibitors. Neo-adjuvant studies in renal cell carcinoma (RCC) may provide a unique opportunity to compare T cell infiltration in a pretreatment renal mass biopsy to a posttreatment nephrectomy specimen, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zahoor, Haris, Pavicic, Paul G., Przybycin, Christopher, Ko, Jennifer, Stephens, Lisa, Radivoyevitch, Tomas, Jia, Xuefei, Diaz-Montero, Claudia Marcela, Finke, James, Rayman, Patricia A., Gilligan, Timothy D., Grivas, Petros, Ornstein, Moshe, Garcia, Jorge A., Rini, Brian I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156035/ https://www.ncbi.nlm.nih.gov/pubmed/30212988 http://dx.doi.org/10.1097/MD.0000000000012344

Ejemplares similares

Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab
por: Zahoor, Haris, et al.
Publicado: (2018)

Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is more
por: Zahoor, Haris, et al.
Publicado: (2017)

Modulation of immune cell infiltrate with sunitinib to improve anti-PD1 therapy in preclinical tumor model
por: Rayman, Patricia, et al.
Publicado: (2015)

Ex vivo conditioning with IL-12 decreases T cell sensitivity to intratumoral INF-γ-induced apoptosis following adoptive transfer
por: Diaz-Montero, C Marcela, et al.
Publicado: (2015)

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Pro
por: Campbell, Steven C., et al.
Publicado: (2022)

Accumulation of MDSC subsets in renal cell carcinoma correlates with grade and progression free survival, and is associated with intratumoral expression of IL-1β, IL-8 and CXCL5
por: Najjar, Yana G, et al.
Publicado: (2014)

IL-12 stimuli during ex vivo expansion not only prevents the upregulation of PD1 on tumor infiltrating adoptively transferred T cells but also on endogenous TILs which results in effective tumor regression
por: Diaz-Montero, C Marcela, et al.
Publicado: (2014)

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
por: Koshkin, Vadim S., et al.
Publicado: (2018)

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
por: Gopalakrishnan, Dharmesh, et al.
Publicado: (2018)

The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma
por: Barata, Pedro Coelho, et al.
Publicado: (2018)

Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature
por: Dawsey, Scott J., et al.
Publicado: (2021)

A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy
por: Ornstein, Moshe C., et al.
Publicado: (2019)

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression
por: Pavicic, Paul G., et al.
Publicado: (2023)

Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma
por: Ford, Jill W., et al.
Publicado: (2022)

Proangiogenic neutrophilic-myeloid-derived suppressor cells emerge via two parallel pathways in renal cell carcinoma and melanoma
por: Ko, Jennifer, et al.
Publicado: (2013)

OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC)
por: Beckermann, Kathryn, et al.
Publicado: (2023)

Differential gene expression in G-MDSC and neutrophils from renal cell carcinoma patients
por: Ko, Jennifer, et al.
Publicado: (2014)

Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma
por: Dawsey, Scott J., et al.
Publicado: (2021)

Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor
por: Ornstein, Moshe C., et al.
Publicado: (2023)

Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date
por: Sheng, Iris Y, et al.
Publicado: (2020)

Correction to: Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor
por: Ornstein, Moshe C., et al.
Publicado: (2023)

Renal Cell Carcinoma Metastasis from Biopsy Associated Hematoma Disruption during Robotic Partial Nephrectomy
por: Caputo, Christopher, et al.
Publicado: (2014)

MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model
por: Diaz-Montero, C Marcela, et al.
Publicado: (2016)

Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab
por: Brown, Landon C., et al.
Publicado: (2021)

Neutrophils from renal cell carcinoma patients show increased expression of immunosuppressive and angiogenic gene profile
por: Obery, Dana R, et al.
Publicado: (2013)

Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates
por: Alaghehbandan, Reza, et al.
Publicado: (2022)

Impact of Laparoscopic Partial Nephrectomy and Open Partial Nephrectomy on Outcomes of Clear Cell Renal Cell Carcinoma
por: Yu, Feng, et al.
Publicado: (2021)

Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
por: Tzeng, Alice, et al.
Publicado: (2021)

The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition
por: Barata, Pedro C., et al.
Publicado: (2017)

Feasibility of using CT radiomic signatures for predicting CD8-T cell infiltration and PD-L1 expression in renal cell carcinoma
por: Varghese, Bino, et al.
Publicado: (2022)

Robotic Partial Nephrectomy Using Robotic Bulldog Clamps
por: Sukumar, Shyam, et al.
Publicado: (2011)

Immune Cell Infiltration Analysis Demonstrates Excessive Mast Cell Activation in Psoriasis
por: Zhang, Yongjun, et al.
Publicado: (2021)

Diagnostic Biopsy Does Not Commonly Induce Intratumoral CD8 T Cell Infiltration in Merkel Cell Carcinoma
por: Koba, Shinichi, et al.
Publicado: (2012)

Characterization of B cells in lupus erythematosus skin biopsies in the context of different immune cell infiltration patterns
por: de Vos, Luka, et al.
Publicado: (2022)

Robotic partial nephrectomy after pazopanib treatment in a solitary kidney with segmental vein thrombosis
por: Garisto, Juan D., et al.
Publicado: (2019)

Laparoscopic retroperitoneoscopic nephrectomy and partial nephrectomy in children
por: Al-hazmi, Hamdan H., et al.
Publicado: (2015)

MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma
por: Neumann, Chase K.A., et al.
Publicado: (2020)

Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)
por: Sheng, Iris Y., et al.
Publicado: (2019)

Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Zargar, Homayoun, et al.
Publicado: (2017)

Perioperative chemotherapy for muscle-invasive bladder cancer: the importance of multidisciplinary management for evidence-based practice and transformative research
por: Koshkin, Vadim S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7olstrqonigev7ku1ul5ejh2fu